A Heterologous Viral Protein Scaffold for Chimeric Antigen Design: An Example PCV2 Virus Vaccine Candidate

A Heterologous Viral Protein Scaffold for Chimeric Antigen Design: An Example PCV2 Virus Vaccine Candidate

Recombinant vaccines have low-cost manufacturing, regulatory requirements, and reduced side effects compared to attenuated or inactivated vaccines. In the porcine industry, post-weaning multisystemic disease syndrome generates economic losses, characterized by progressive weight loss and weakness in...

Full description

Bibliographic Details
Main Authors: Emilio Lamazares, Fernando Gutiérrez, Angela Hidalgo, Nicolas A. Gutiérrez, Felipe I. Espinoza, Oliberto Sánchez, Marcelo Cortez-San Martín, Carolina Mascayano, Javier González, José Saavedra, Claudia Altamirano, Manuel Mansur, Álvaro Ruiz, Jorge R. Toledo
Format: Article
Language:English
Published: MDPI AG 2020-03-01
Series:Viruses
Subjects:
PCV2 virus
recombinant antigens production
vaccines
biotechnology strategies
Online Access:https://www.mdpi.com/1999-4915/12/4/385

Internet

https://www.mdpi.com/1999-4915/12/4/385

Similar Items